| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kintara Therapeutics, Inc. | Director | Options (Right to Buy) | 8,500 | 30 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KTRA | Kintara Therapeutics, Inc. | 30 Aug 2023 | 1 | $0 | 4 | Director | 01 Sep 2023, 19:00 |
| KTRA | Kintara Therapeutics, Inc. | 01 Jul 2022 | 1 | $0 | 4 | Director | 05 Jul 2022, 16:05 |
| KTRA | Kintara Therapeutics, Inc. | 22 Sep 2021 | 1 | $0 | 4 | Director | 22 Sep 2021, 20:40 |